LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 388 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $618,000 | -30.2% | 8,500 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $886,000 | +4.7% | 8,500 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $846,000 | -12.8% | 8,500 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $970,000 | -9.3% | 8,500 | 0.0% | 0.01% | -12.5% |
| Q1 2019 | $1,069,000 | +31.3% | 8,500 | +41.7% | 0.01% | +14.3% |
| Q4 2018 | $814,000 | -1.1% | 6,000 | +100.0% | 0.01% | +16.7% |
| Q3 2018 | $823,000 | +32.3% | 3,000 | 0.0% | 0.01% | +50.0% |
| Q2 2018 | $622,000 | -37.2% | 3,000 | -50.0% | 0.00% | -42.9% |
| Q1 2018 | $991,000 | +20.6% | 6,000 | 0.0% | 0.01% | +40.0% |
| Q4 2017 | $822,000 | +20.7% | 6,000 | +20.0% | 0.01% | +25.0% |
| Q3 2017 | $681,000 | +12.2% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $607,000 | +14.7% | 5,000 | 0.0% | 0.00% | +33.3% |
| Q1 2017 | $529,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |